PACIFIC BIOSCIENCES CALIF IN's ticker is PACB and the CUSIP is 69404D108. A total of 260 filers reported holding PACIFIC BIOSCIENCES CALIF IN in Q1 2023. The put-call ratio across all filers is 0.16 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,016 | -75.5% | 121,809 | -60.9% | 0.00% | -66.7% |
| Q2 2023 | $4,141 | +130.4% | 311,356 | +100.6% | 0.00% | +200.0% |
| Q1 2023 | $1,797 | +73.1% | 155,179 | +22.2% | 0.00% | – |
| Q4 2022 | $1,038 | -99.8% | 126,968 | +37.6% | 0.00% | -100.0% |
| Q3 2022 | $536,000 | -32.3% | 92,292 | -48.5% | 0.00% | – |
| Q2 2022 | $792,000 | -45.9% | 179,324 | +11.5% | 0.00% | -100.0% |
| Q1 2022 | $1,463,000 | -95.0% | 160,814 | -88.8% | 0.00% | -80.0% |
| Q4 2021 | $29,302,000 | +54.5% | 1,432,220 | +92.9% | 0.01% | -37.5% |
| Q3 2021 | $18,967,000 | +816.7% | 742,325 | +1154.6% | 0.01% | +700.0% |
| Q2 2021 | $2,069,000 | -66.7% | 59,168 | -68.3% | 0.00% | -66.7% |
| Q1 2021 | $6,208,000 | +304.4% | 186,357 | +214.7% | 0.00% | +200.0% |
| Q4 2020 | $1,535,000 | +102.5% | 59,214 | -22.9% | 0.00% | – |
| Q3 2020 | $758,000 | +75.9% | 76,805 | -38.5% | 0.00% | – |
| Q2 2020 | $431,000 | +86.6% | 124,930 | +65.6% | 0.00% | – |
| Q1 2020 | $231,000 | -94.0% | 75,434 | -90.0% | 0.00% | -100.0% |
| Q4 2019 | $3,880,000 | +35.4% | 754,917 | +35.9% | 0.00% | 0.0% |
| Q3 2019 | $2,866,000 | +64.7% | 555,594 | +93.2% | 0.00% | +100.0% |
| Q2 2019 | $1,740,000 | -32.3% | 287,612 | -19.1% | 0.00% | -50.0% |
| Q1 2019 | $2,569,000 | -42.0% | 355,433 | -40.6% | 0.00% | -33.3% |
| Q4 2018 | $4,430,000 | +431.2% | 598,555 | +288.6% | 0.00% | +200.0% |
| Q3 2018 | $834,000 | +382.1% | 154,027 | +213.9% | 0.00% | – |
| Q2 2018 | $173,000 | +158.2% | 49,072 | +50.7% | 0.00% | – |
| Q1 2018 | $67,000 | -75.2% | 32,563 | -68.1% | 0.00% | – |
| Q4 2017 | $270,000 | +1976.9% | 102,238 | +4158.1% | 0.00% | – |
| Q3 2017 | $13,000 | +550.0% | 2,401 | +271.7% | 0.00% | – |
| Q2 2017 | $2,000 | -91.3% | 646 | -85.5% | 0.00% | – |
| Q1 2017 | $23,000 | -80.8% | 4,459 | -85.9% | 0.00% | – |
| Q4 2016 | $120,000 | -71.9% | 31,612 | -33.8% | 0.00% | – |
| Q3 2016 | $427,000 | +6000.0% | 47,740 | +4177.8% | 0.00% | – |
| Q2 2016 | $7,000 | -99.0% | 1,116 | -98.7% | 0.00% | -100.0% |
| Q1 2016 | $668,000 | +10.8% | 83,445 | +79.9% | 0.00% | 0.0% |
| Q4 2015 | $603,000 | +813.6% | 46,380 | +108.8% | 0.00% | – |
| Q3 2015 | $66,000 | +1000.0% | 22,214 | +1684.3% | 0.00% | – |
| Q2 2015 | $6,000 | -53.8% | 1,245 | -51.8% | 0.00% | – |
| Q1 2015 | $13,000 | -78.0% | 2,582 | -69.2% | 0.00% | – |
| Q4 2014 | $59,000 | +43.9% | 8,376 | -19.4% | 0.00% | – |
| Q3 2014 | $41,000 | -74.7% | 10,390 | -61.6% | 0.00% | – |
| Q2 2014 | $162,000 | +44.6% | 27,024 | +21.3% | 0.00% | – |
| Q1 2014 | $112,000 | -17.0% | 22,278 | -17.3% | 0.00% | – |
| Q4 2013 | $135,000 | +1400.0% | 26,945 | +1538.0% | 0.00% | – |
| Q3 2013 | $9,000 | -90.0% | 1,645 | -95.4% | 0.00% | – |
| Q2 2013 | $90,000 | – | 35,581 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 2,660,000 | $24,206,000 | 11.49% |
| Data Collective II GP, LLC | 164,249 | $1,495,000 | 5.44% |
| Decheng Capital Management III (Cayman), LLC | 1,463,872 | $13,321,000 | 4.08% |
| SB Management Ltd | 1,886,107 | $17,164,000 | 3.33% |
| Casdin Capital, LLC | 7,990,652 | $72,715,000 | 3.26% |
| ORACLE INVESTMENT MANAGEMENT INC | 1,225,395 | $11,151,000 | 2.20% |
| Jackson Square Partners, LLC | 22,542,589 | $205,137,000 | 2.04% |
| BOURNE LENT ASSET MANAGEMENT INC | 556,865 | $5,067,000 | 1.59% |
| ARK Investment Management | 27,259,521 | $248,062,000 | 1.04% |
| Nikko Asset Management Americas, Inc. | 14,021,205 | $127,873,000 | 0.94% |